Search
Generic filters
Search in excerpt

Un FNB pour chaque investisseur.

HSAV

FNB Horizons Compte maximiseur d’espèces

Prix
$103.67
$0.06
0.06%
Valeur liquidative
$103.3735
$0.0115
0.01%

Indices

Catégorie de Société - Rendement Total

Aperçu du FNB
En savoir plus sur HSAV

QQCC

FNB Horizons Options d’achat couvertes NASDAQ-100

Prix
$9.89
$0.33
3.45%
Valeur liquidative
$9.9048
$0.0191
0.19%

Active

Options D'achat Couvertes

Aperçu du FNB
En savoir plus sur QQCC

HAC

FNB Horizons à rotation saisonnière

Prix
$26.04
$0.01
0.04%
Valeur liquidative
$26.0362
$0.0043
0.02%

Active

Stratégique

Aperçu du FNB
En savoir plus sur HAC
Explorer tous les produits
Search
Generic filters
Search in excerpt
Retour à Médias

Cannabis and the Greatest Tailwind

Banner 

BY: HANS ALBRECHT, CIM®, FCSI, VICE-PRESIDENT, PORTFOLIO MANAGER AND OPTIONS STRATEGIST, HORIZONS ETFS

June 11, 2018

As we approach the final destination in Canada’s journey toward legalized recreational cannabis, it’s important to recognize that we’re about to experience a big moment. After all, it’s not every year that prohibition ends for a controlled substance! The steps taken have been significant and brave, but as they say, every journey begins with a first step – what was once thought almost unthinkable is almost upon us.

There are obvious and immediate beneficiaries in the cannabis production and distribution space, but the biggest tailwind for this industry will be something that people don’t think about as much – changing sentiment towards something that has held a stigma for so long. I think you have to see past the short-term to see the real potential. Yes, there will be immediate adopters in a country that already has a lot of pot smokers – in fact with some of the higher usage rates in the world1. But a real opportunity also lies in grabbing fresh market share and addressing cannabis as a product with varied and distinct benefits that could replace some existing drugs – including opioid painkillers, sleep aids, anti-inflamatories, etc. I have spoken to people who haven’t smoked in 20 years but are taking another look at it as it starts to get de-stigmatized, in large part by the act of decriminalization itself.

I believe the next wave in removing the stigma will be within the medical industry. Some cannabis seekers are currently being turned away by their family doctors who admittedly know little about it. I think this tide will turn as doctors slowly embrace the variety of marijuana strains and their potential applications. There are types of marijuana that have virtually no THC in them, instead containing CBD – giving the user no high but potentially effective for muscle aches, insomnia, anxiety, etc.

Where’s the fun in that? Well, that’s really the point – the recreational market will be about fun and social lubricating. The ‘un-fun’ side will blossom slowly and surely as the benefits of marijuana are better understood and exploited. The potential for cannabis to take the place of opioids and other drugs for pain and discomfort is yet to be fully understood. No longer do you have to meet some guy in a back alley. Now, you can visit beautiful websites offering products with nice packaging and very detailed descriptions. And you can get those products discreetly shipped to your home. Alcohol doesn’t really have a recreational and medical crossover, whereas cannabis does. As producers find new ways to engineer and position it, I believe cannabis will eventually become very well accepted by society.

In fact, it’s happening already. Within the U.S., national pollster Gallup notes that nearly two-thirds of all respondents in its October 2017 poll favoured the idea of legalizing weed2. That's up 39 percentage points from where support stood for legalization in 1995. The existing user base may lead the way – but time, education and understanding will work for the long haul. The greatest tailwind to cannabis will be a changing attitude and acceptance. As the stigma and judgement dissolves, that could bode very well for long-term cannabis investors.

1 Source: https://www.telegraph.co.uk/travel/maps-and-graphics/mapped-the-countries-that-smoke-the-most-cannabis/
2 Source: http://news.gallup.com/poll/221018/record-high-support-legalizing-marijuana.aspx

The views/opinions expressed herein may not necessarily be the views of Horizons ETFs Management (Canada) Inc. All comments, opinions and views expressed are of a general nature and should not be considered as advice to purchase or to sell mentioned securities. Before making any investment decision, please consult your investment advisor or advisors.

Mots-clés
Non classifié(e)

Get Horizons insights in your inbox

"*" indique un champ obligatoire

Veuillez indiquer si vous êtes :*
* Indique un champ obligatoire

Publications connexes

À Horizons ETFs, nous croyons que l’éducation est synonyme d’autonomisation. Nous nous efforçons de fournir aux investisseurs canadiens les connaissances et les outils dont ils ont besoin pour naviguer dans le monde des placements. Qu’il s’agisse des connaissances de base sur les FNB ou de sujets plus complexes comme le fonctionnement de notre gamme de fonds inverses et à effet de levier, notre bibliothèque d’apprentissage exhaustive vise à être accessible à tous les investisseurs, des débutants aux spéculateurs expérimentés!